Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

TVTX holding history

Travere Therapeutics, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVTX overview All 13F holders of TVTX Full Q2 2026 holdings

Shares (Q2 2026): 8,802
Value: $500.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of TVTX by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	8,802	$500.0K	<0.1%	+995+12.7%	Added	Holders
Q1 2026	7,807	$231.9K	<0.1%	−252−3.1%	Reduced	Holders
Q4 2025	8,059	$307.9K	<0.1%	+8,059	New	Holders